John Cravero, PhD


Office of Science Patent Attorney
U.S. Department of Energy
Argonne, IL

J.D., Chicago-Kent College of Law, 2012
Ph.D., Molecular Medicine, 2008
Wake Forest University
School of Medicine
Winston-Salem, NC

B.A., Augustana College, Rock Island, IL

Research Interest:

Osteoarthritis, IGF-1 signaling pathways in the chondrocyte, the decrease in the chondrocyte’s response to IGF-1 that occurs with age and OA, and the role of age-related oxidative stress and how it contributes to the decreased IGF-1 response of the chondrocyte.
Postdoctoral Northwest University, August 2009


Cravero JD, Carlson CS, Im HJ, Yammani RR, Long D, Loeser RF. Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis. Arthritis Rheum. 2009 Feb;60(2):492-500.
Starkman, B.G., Cravero, J.D., DelCarlo, M. Jr., Loeser, R.F. IGF-1 stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI3-kinase pathway but not ERK MAPK. Biochem. J. (2005) 389: 723-729.

For a listing of additional publications, refer to PubMed, a service provided by the National Library of Medicine.

Quick Reference

Contact Information
Molecular Medicine and Translational Science Graduate Program

Office 336-713-4259

Kay Collare


Find A Doctor Ways to Give
Last Updated: 10-22-2015
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.